Brian Hess
Principal investigator, leads REVBIO, INC..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$12.3MFederal grants as PI10 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
10 awards · $12.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 23, 2026 | NIH | SBIR Phase II Use of an Innovative Pre-Formed Structural Scaffold for Reconstruction of Segmental Bone Loss in a Zygomaticomaxillary Complex Model | $1.3M | REVBIO, INC. |
| Aug 5, 2025 | NIH | SBIR Phase II A Pilot Clinical Study for a Novel Bioresorbable Bone Adhesive to Evidence Improved Cranial Flap Fixation Based on Radiographic Imaging and Patient Reported Outcomes | $715K | REVBIO, INC. |
| Aug 30, 2024 | NIH | SBIR Phase II A Pilot Clinical Study for a Novel Bioresorbable Bone Adhesive to Evidence Improved Cranial Flap Fixation Based on Radiographic Imaging and Patient Reported Outcomes | $1.7M | REVBIO, INC. |
| Sep 30, 2023 | NIH | SBIR Phase II Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging Patients | $1.7M | REVBIO, INC. |
| Aug 15, 2022 | NIH | SBIR Phase I Improved Treatment of Vertebral Compression Fractures for Elderly Patients Using an Image-Guided, Percutaneous Delivery of a Novel Bone Adhesive | $375K | REVBIO, INC. |
| Apr 14, 2022 | NIH | SBIR Phase II Improved Treatment of Distal Radius Fractures Using an Image-Guided, Percutaneous Delivery of a Novel Bone Adhesive | $625K | REVBIO, INC. |
| May 5, 2021 | NIH | SBIR Phase II A Novel Bioresorbable Bone Adhesive Used to Fixate Cranial Flaps and Reduce Infection Rates | $1.2M | REVBIO, INC. |
| Apr 1, 2021 | NIH | SBIR Phase II Improved Treatment of Distal Radius Fractures Using an Image-Guided, Percutaneous Delivery of a Novel Bone Adhesive | $2.0M | REVBIO, INC. |
| May 1, 2020 | NIH | SBIR Phase II A Novel Bioresorbable Bone Adhesive Used to Fixate Cranial Flaps and Reduce Infection Rates | $2.5M | REVBIO, INC. |
| Apr 1, 2018 | NIH | STTR Phase I Formation and Structural Property Relationships of a Tetracalcium Phosphate Bone Adhesive Biomaterial | $197K | REVBIO, INC. with LAUNCHPAD MEDICAL, LLC |
Peer ranks
Federal funding#45
Awards as PI#141
Patents#505
Companies
- REVBIO, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.